Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
Systematic Review
70%
Congestive Heart Failure
70%
Aortic Stenosis
65%
Meta-Analysis
61%
Apoplexy
34%
Prevalence
33%
Valvular Heart Disease
28%
Coronary Artery Disease
28%
Brain Natriuretic Peptide
26%
Implantable Automatic Defibrillator
26%
Cardiology
25%
Diseases
25%
Mitral Insufficiency
24%
Percutaneous Coronary Intervention
24%
Heart Amyloidosis
23%
Hypervolemia
23%
Chronic Total Occlusion
23%
Cardiovascular Disease
22%
Echocardiography
22%
Cardiovascular System
22%
Defibrillator
21%
Aortic Valve Replacement
21%
Ejection Fraction
21%
Acute Heart Infarction
19%
Hospital Mortality
19%
Magnetic Resonance Imaging
18%
Heart Surgery
17%
Aortic Valve
17%
Diagnosis
16%
Cardiac Magnetic Resonance Imaging
16%
Acute Coronary Syndrome
16%
National Inpatient Sample
16%
Revascularization
16%
Pooled Analysis
16%
Ventricular Tachycardia
16%
Heart Left Ventricle Ejection Fraction
15%
Coronary Artery Aneurysm
15%
Geriatrics
15%
Long-Term Care
15%
Thromboembolism
15%
Mitral Valve Repair
15%
Heart Failure with Preserved Ejection Fraction
15%
Computed Tomography Angiography
15%
Cardiovascular Risk
15%
Coronary Angiography
15%
Adverse Event
15%
Bleeding
15%
Hemodynamic
14%
Odds Ratio
14%
Hazard Ratio
14%
Myocardial Infarction
13%
Tricuspid Insufficiency
13%
Technetium-99
12%
Computer Assisted Tomography
12%
All Cause Mortality
12%
Atrial Fibrillation
12%
Kaplan Meier Method
11%
Clinical Trial
11%
Pulmonary Hypertension
11%
Placebo
11%
Thorax Pain
11%
Quality of Life
11%
Antithrombotic
11%
Pulmonary Artery
11%
Randomized Controlled Trial
11%
Cardiac Resynchronization Therapy
11%
Dobutamine
11%
Aortic Valve Stenosis
10%
Angiography
10%
Sex Difference
10%
Combination Therapy
10%
Ventricular Fibrillation
10%
Heart Atrium Pacing
10%
Natriuretic Factor
10%
Mortality Rate
10%
EuroSCORE
9%
In Vitro
9%
Comorbidity
9%
Valve Replacement
9%
Retrospective Cohort Study
9%
Proportional Hazards Model
9%
Heart Valve
9%
Nephrologist
9%
Arteriosclerosis Obliterans
9%
Anticoagulation
9%
Valvuloplasty
9%
Health Care Cost
9%
Amino Terminal Sequence
8%
Primary Percutaneous Coronary Intervention
8%
Aortic Insufficiency
8%
Patient Referral
8%
Diagnostic Error
8%
Cardiovascular Imaging
8%
Bicuspid Aortic Valve
8%
Heart Ventricle Remodeling
8%
Thrombus
8%
Cardiogenic Shock
8%
ST Segment Elevation Myocardial Infarction
8%
Heart Injury
8%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
23%
Congestive Heart Failure
21%
Hypervolemia
15%
Pulmonary Hypertension
15%
Heart Amyloidosis
15%
Chronic Total Occlusion
15%
Cerebrovascular Accident
13%
Empagliflozin
12%
Placebo
11%
Adverse Event
11%
Cohort Study
9%
Peripheral Occlusive Artery Disease
9%
Coronary Artery Disease
9%
Acute Heart Infarction
9%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Heart Injury
8%
Membrane Metalloendopeptidase
8%
Cardiogenic Shock
8%
Acute Kidney Failure
8%
Aortic Stenosis
8%
South American Blastomycosis
7%
Rosuvastatin
7%
Atorvastatin
7%
Low Density Lipoprotein Cholesterol
7%
Prospective Cohort Study
7%
Prosthetic Valve Dysfunction
7%
Acute Coronary Syndrome
7%
Thrombus
7%
Kidney Artery Stenosis
7%
Heart Failure with Preserved Ejection Fraction
7%
Riociguat
7%
Mycosis
7%
Hypertensive Factor
7%
Ertugliflozin
7%
Coronary Artery Aneurysm
7%
Ivabradine
7%
Valvular Heart Disease
7%
Transthyretin
7%
Myocarditis
7%
Syndrome
7%
Virus Infection
7%
Cluster Randomized Trial
7%
Interleukin 6
7%
End Stage Renal Disease
7%
Heart Infarction
7%
Dobutamine
7%
Cause of Death
7%
Heart Ventricle Tachycardia
7%
Heart Ventricle Arrhythmia
7%
Aortic Valve Stenosis
7%
Angiotensin
7%
Clusterin
7%
Angiotensin I
7%
Vitamin K Group
7%
Venous Thromboembolism
7%
Hospital Mortality
7%
Adverse Device Effect
7%
High Density Lipoprotein
7%
Disease
6%
Hormone Precursor
6%
Heart Failure with Reduced Ejection Fraction
5%
Statin (Protein)
5%
Technetium 99m
5%
Hypertension
5%
Omega-3 Fatty Acid
5%